SEC Form 4/A · accession 0001209191-18-024864
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Thomas B Neff
Officer — Chief Executive Officer · Director
Period of report
Dec 19, 2016
Accepted (ET)
Apr 13, 2018 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.025 | Dec 19, 2016 | M | 24,844 | D | — | Aug 20, 2017 | Common Stock | 24,844 | 0 | D |
Explanation of responses
- F1Fully vested.
Remarks
This Form 4/A is being filed to add the line item to table 2, which was inadvertently omitted from the original filing.